Saturation mutagenesis of the β subunit of the human granulocyte- macrophage colony-stimulating factor receptor shows clustering of constitutive mutations, activation of ERK MAP kinase and STAT pathways, and differential β subunit tyrosine phosphorylation

Blood

Volumn 92, Issue 6, 1998, Pages 1989-2002

  Jenkins, Brendan J ^a   Blake, Timothy J ^a   Gonda, Thomas J ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ALPHA CHAIN; ARTICLE; BETA CHAIN; BINDING AFFINITY; CELL PROLIFERATION; CRYSTAL STRUCTURE; DIMERIZATION; HUMAN; HUMAN CELL; MUTAGENESIS; MUTATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; STOICHIOMETRY;

EID: 0032531031     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.6.1989.418k18_1989_2002     Document Type: Article

References (75)

1. Gearing DP, King JA, Cough NM, Nicola NA: Expression cloning of a receptor for human granulocyte-macrophage colony-stimulating factor. EMBO J 8:3667, 1989
2. Hayashida K, Kitamura T, Gorman DM, Arai K, Yokota T, Miyajima A: Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony-stimulating factor (GM-CSF): Reconstitution of a high-affinity GM-CSF receptor. Proc Natl Acad Sci USA 87:9655, 1990
3. Kitamura T, Sato N, Arai K, Miyajima A: Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for the human IL-3 and GM-CSF receptors. Cell 66:1165, 1991
4. Tavernier J, Devos R, Cornelis S, Tuypens T, Van der Heyden J, Fiers W, Plaetinck G: A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific a chain and a β chain shared with the receptor for GM-CSF. Cell 66:1175, 1991
5. Sakamaki K, Miyajima I, Kitamura T, Miyajima A: Critical cytoplasmic domains of the common β subunit of the human GM-CSF, IL-3 and IL-5 receptors for growth signal transduction and tyrosine phosphorylation. EMBO J 11:3541, 1992
6. Mui AL, Miyajima A: Cytokine receptors and signal transduction. Prog Growth Factor Res 5:15, 1994
7. Duronio V, Clark Lewis I, Federsppiel B, Wieler JS, Schrader JW: Tyrosine phosphorylation of receptor β subunits and common substrates in response to interleukin-3 and granulocyte-macrophage colony-stimulating factor. J Biol Chem 267:21856, 1992
8. Mui AL, Wakao H, O'Farrell AM, Harada N, Miyajima A: Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STATS homologs. EMBO J 14:1166, 1995
9. Silvennoinen O, Witthuhn BA, Quelle FW, Cleveland JL, Yi T, Ihle JN: Structure of the murine Jak2 protein-tyrosine kinas? and its role in interleukin 3 signal transduction. Proc Natl Acad Sci USA 90:8429, 1993
10. Sato N, Sakamaki K, Terada N, Arai K, Miyajima A: Signal transduction by the high-affinity GM-CSF receptor: Two distinct cytoplasmic regions of the common β subunit responsible for different signaling. EMBO J 12:4181, 1993
11. c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 14:4335, 1994
12. De Vos P, Ultsch M, Kossiakoff AA: Human growth hormone and extracellular domain of its receptor: Crystal structure of the complex. Science 255:306, 1992
13. Alexander WS, Metcalf D, Dunn AR: Point mutations within a dimer interface homology domain of c-Mpl induce constitutive receptor activity and tumorigenicity. EMBO J 14:5569, 1995
14. Watowich SS, Yoshimura A, Longmore GD, Hilton DJ, Yoshimura Y, Lodish HF: Homodimerization and constitutive activation of the erythropoietin receptor. Proc Natl Acad Sci USA 89:2140, 1992
15. Watowich SS, Hilton DJ, Lodish HF: Activation and inhibition of erythropoietin receptor function: Role of receptor dimerization. Mol Cell Biol 14:3535, 1994
16. Livnah O, Stura EA, Johnson DL, Middleton SA, Mulcahy LS, Wrighton NC, Dower WJ, Jolliffe LK, Wilson IA: Functional mimicry of a protein hormone by a peptide agonist: The Epo receptor complex at 2.8 A. Science 273:464, 1996
17. Eder M, Ernst TJ, Ganser A, Jubinsky PT, Inhorn R, Hoelzer D, Griffin JD: A low affinity chimeric human α/β-granulocyte-macrophage colony-stimulating factor receptor induces ligand-dependent proliferation in a murine cell line. J Biol Chem 269:30173, 1994
18. Stomski F, Sun Q, Bagley C, Woodcock J, Goodall G, Andrews R, Berndt M, Lopez A: Human interleukin-3 (IL-3) induces disulphide-linked IL-3 receptor α and β chain heterodimerization which is required for receptor activation but not high affinity binding. Mol Cell Biol 16:3035, 1996
19. Takaki S, Kanazawa H, Shiiba M, Takatsu K: A critical cytoplasmic domain of the interleukin-5 (IL-5) receptor a chain and its function in IL-5-mediated growth signal transduction. Mol Cell Biol 14:7404, 1994
20. Muto A, Watanabe S, Miyajima A, Yokota T, Arai K: High affinity chimeric human granulocyte-macrophage colony-stimulating factor receptor carrying the cytoplasmic domain of the β subunit but not the α subunit transduces growth promoting signals in Ba/F3 cells. Biochem Biophys Res Commun 208:368, 1995
21. Muto A, Watanabe S, Miyajima A, Yokota T, Arai K: The β subunit of human granulocyte-macrophage colony-stimulating factor receptor forms a homodimer and is activated via association with the α subunit. J Exp Med 183:1911, 1996
22. Lia F, Rajotte D, Clark SC, Hoang T: A dominant negative granulocytye-macrophage colony-stimulating factor receptor α chain reveals the multimeric structure of the receptor complex. J Biol Chem 271:28287, 1996
23. Bagley CJ, Woodcock JM, Stomski FC, Lopez AF: The structural and functional basis of cytokine receptor activation: Lessons from the common β subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3) and IL-5 receptors. Blood 89:1471, 1997
24. Jenkins BJ, D'Andrea RJ, Gonda TJ: Activating point mutations in the common β subunit of the human GM-CSF, IL-3 and IL-5 receptors suggest the involvement of β subunit dimerization and cell type-specific molecules in signalling, EMBO J 14:4276, 1995
25. Bargmann CI, Hung MC, Weinberg RA: Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p 185. Cell 45:649, 1986
26. Weiner DB, Liu J, Cohen JA, Williams WV, Greene MI: A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature 339:230, 1989
27. Gonda TJ, D'Andrea RJ: Activating mutations in cytokine receptors: Implications for receptor function and role in disease. Blood 89:355, 1997
28. Jenkins BJ, Bagley CJ, Woodcock J, Lopez AF, Gonda TJ: Interacting residues in the extracellular region of the common β subunit of the human GM-CSF, IL-3 and IL-5 receptors involved in constitutive activation. J Biol Chem 271:29707, 1996
29. Pear WS, Nolan GP, Scott ML, Baltimore D: Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90:8392, 1993
30. Dexter TM, Garland J, Scott D, Scolnick E, Metcalf D: Growth of factor-dependent haemopoietic precursor cell lines. J Exp Med 152:1036, 1980
31. Hatakeyama M, Mori H, Doi T, Taniguchi T: A restricted cytoplasmic region of IL-2 receptor β chain is essential for growth signal transduction but not for ligand binding and internalization. Cell 59:837, 1989
32. Barry SC, Bagley CJ, Phillips J, Dottore M, Cambareri B, Moretti P, D'Andrea R, Goodall GJ, Shannon MF, Vadas MA, Lopez AF: Two contiguous residues in human interleukin-3, Asp21 and Glu22, selectively interact with the α- and β-chains of its receptor and participate in function. J Biol Chem 269:8488, 1994
33. Rayner JR, Gonda TJ: A simple and efficient procedure for generating stable expression libraries by cDNA cloning in a retroviral vector. Mol Cell Biol 14:880, 1994
34. Johnson GR: Colony formation in agar by adult bone marrow multipotential hemopoietic cells. J Cell Physiol 103:371, 1980
35. Hughes SH, Payvar F, Spector D, Schimke RT, Robinson HL, Payne GS, Bishop JM, Varmus HE: Heterogeneity of genetic loci in chickens: Analysis of endogenous viral and normal genes by cleavage of DNA with restriction endonucleases. Cell 18:347, 1979
36. Woodcock JM, Zacharakis B, Plaetinck G, Bagley CJ, Qiyu S, Hercus TR, Tavernier J, Lopez AF: Three residues in the common β chain of the human GM-CSF, IL-3 and IL-5 receptors are essential for GM-CSF and IL-5 but not IL-3 high affinity binding and interact with Glu21 of GM-CSF. EMBO J 13:5176, 1994
37. Barry SC, Moretti PAB, Korpeleinen E, D'Andrea R, Lopez AF, Vadas MA, Goodall GJ: Roles of the N-terminal and C-terminal domains of the IL-3 receptor a chain in receptor function. Blood 89:842, 1997
38. Durstin M, Inhorn RC, Griffin JD: Tyrosine phosphorylation of She is not required for proliferation or viability signalling by granulocyte-macrophage colony-stimulating factor in hematopoietic cell lines. J Immunol 157:534, 1996
39. Marshall CJ: Specificity of receptor tyrosine kinase signalling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179, 1995
40. Ihle JN: The Janus protein tyrosine kinase family and its role in cytokine signaling. Adv Immunol 60:1, 1995
41. fes, STAT1 p91 and STAT3 p92 in polymorphonuclear leukocytes. J Biol Chem 271:3562, 1996
42. Watanabe S, Itoh T, Arai K: JAK2 is essential for activation of c-fos and c-myc promoters and cell proliferation through the human granulocyte-macrophage colony-stimulating factor receptor in BA/F3 cells. J Biol Chem 271:12681, 1996
43. Gouilleux F, Wakao H, Mundt M, Groner B: Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J 13:4361, 1994
44. Sakai I, Kraft AS: The kinase domain of Jak2 mediates induction of Bcl-2 and delays cell death in hematopoietic cells. J Biol Chem 272:12350, 1997
45. Quelle FW, Thierfelder WE, Witthuhn BA, Tang B, Cohen SL, Ihle JN: Phosphorylation and activation of the DNA binding activity of purified Stall by the Janus protein-tyro sine kinases and the epidermal growth factor receptor. J Biol Chem 270:20775, 1995
46. Watanabe S, Itoh T, Arai K: Roles of JAK kinases in human GM-CSF receptor signal transduction. J Allergy Clin Immunol 98: S183, 1996
47. Grube BJ, Cochrane CG: Identification of a regulatory domain of the interleukin-6 receptor. J Biol Chem 269:20791, 1994
48. Yawata H, Yasukawa K, Natsuka S, Murakami M, Yamasaki K, Hibi M, Taga T, Kishimoto T: Structure-function analysis of human IL-6 receptor: Dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130. EMBO J 12:1705, 1993
49. Sternberg MJ, Gullick WJ: Neu receptor dimerization. Nature 339:587, 1989
50. Hofmann K, Stoffel W: TMbase - A database of membrane-spanning protein segments. Biol Chem Hoppe-Seyler 347:166, 1993
51. Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, Hamaguchi M, Taga T, Kishimoto T: Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc Natl Acad Sci USA 88:11349, 1991
52. Miura O, Cleveland JL, Ihle JN: Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors. Mol Cell Biol 13:1788, 1993
53. DaSilva L, Howard OMZ, Rui H, Kirken RA, Farrar WL: Growth signalling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors. J Biol Chem 269:18267, 1994
54. Goldsmith MA, Xu W, Amaral MC, Kuczek ES, Greene WC: The cytoplasmic domain of the interleukin-2 receptor β chain contains both unique and functionally redundant signal transduction elements. J Biol Chem 269:14698, 1994
55. Joneja B, Wojchowski DM: Mitogenic signalling and inhibition of apoptosis via the erythropoietin receptor box-1 domain. J Biol Chem 272:11176, 1997
56. Drachman JG, Kaushansky K: Dissecting the thrombopoietin receptor: Functional elements of the Mpl cytoplasmic domain. Proc Natl Acad Sci USA 94:2350, 1997
57. MAPK. Blood 86:3698, 1995
58. Kitayama H, Kanakura Y, Furitsu T, Tsujimura T, Oritani K, Ikeda H, Sugahara H, Mitsui H, Kanayama Y, Kitamura Y, Matsuzawa Y: Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 85:790, 1995
59. Inborn RC, Carlesso N, Durstin M, Frank DA, Griffin JD: Identification of a viability domain in the granulocyte/macrophage colony-stimulating factor receptor β-chain involving tyrosine-750. Proc Natl Acad Sci USA 92:8665, 1995
60. Winston LA, Hunter T: JAK2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone. J Biol Chem 270:30837, 1995
61. Yin T, Shen R, Feng GS, Yang YC: Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases. J Biol Chem 272:1032, 1997
62. ras-dependent manner. Proc Natl Acad Sci USA 93:11681, 1996
63. Onishi M, Mui AL, Morikawa Y, Cho LC, Kinoshita S, Nolan GP, Gorman DM, Miyajima A, Kitamura T: Identification of an oncogenic form of the thrombopoietin receptor MPL using retrovirus-mediated gene transfer. Blood 88:1399, 1996
64. Chao JR, Chen CS, Wang TF, Tseng LH, Tsai JJ, Kuo ML, Yen JJY, Yang Yen HF: Characterization of factor-independent variants derived from TF-1 hematopoietic progenitor cells: The role of the Raf/MAP kinase pathway in the anti-apoptotic effect of GM-CSF. Oncogene 14:721, 1997
65. van der Bruggen T, Caldenhoven E, Kanters D, Coffer P, Raaijmakers JAM, Lammers JWJ. Koenderman L: lnterleukin-5 signalling in human eosinophils involves JAK2 tyrosine kinase and Stat 1α. Blood 85:1442, 1995
66. Mui AL, Wakao H, Kinoshita T, Kitamura T., Miyajima A: Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: Role of Stat5 in proliferation. EMBO J 15:2425, 1996
67. Damen JE, Wakao H, Miyajima A, Krosl J, Humphries RK, Cutler RL, Krystal G: Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J 14:5557, 1995
68. Klingmuller U, Bergelson S, Hsiao JG, Lodish HF: Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5. Proc Natl Acad Sci USA 93:8324, 1996
69. Iwatsuki K, Endo T, Misawa H, Yokouchi M, Matsumoto A, Ohtsubo M, Mori KJ, Yoshimura A: STAT5 activation correlates with erythropoietin receptor-mediated erythroid differentiation of an erythroleukemia cell line. J Biol Chem 272:8149, 1997
70. Chin H. Nakamura N, Kamiyama R, Miyasaka N, Ihle JN, Miura O: Physical and functional interactions between Stat5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3. Blood 88:4415, 1996
71. Fujii H, Nakagawa Y, Schindler U, Kawahara A, Mori K, Gouilleux F, Groner B, Ihle JN, Minami Y, Miyazaki T, Taniguchi T: Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor β chain but is not essential for the proliferative signal transmission. Proc Natl Acad Sci USA 92:5482, 1995
72. Goodall GJ, Bagley CJ, Vadas MA, Lopez AF: A model for the interaction of the GM-CSF, IL-3 and IL-5 receptors with their ligands. Growth Factors 8:87, 1993
73. Bazan JF: Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87:6934, 1990
74. Kraulis P: MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J Appl Cryst 24:946, 1991
75. Merrit EA, Murphy MEP: Raster3D Version 2.0, a program for photorealistic molecular graphics. Acta Crsyt D50:869, 1994